Latest News About Vitamin K

Here are the latest developments on vitamin K from recent news sources:

• Newborn vitamin K recommendations and formulations continue to be discussed, with ongoing evaluation of oral versus injectable regimens in some countries. Recent coverage highlights that while injectable vitamin K may be more effective in preventing vitamin K deficiency bleeding, well-structured oral regimens can also achieve very low incidence rates in certain populations.[1]

• Regulatory and market news includes FDA approvals and recalls related to vitamin K–related products, such as phytonadione (vitamin K1) formulations. These reports cover product approvals for coagulation-related therapies as well as recalls due to stability or quality concerns.[2]

• Observational research continues to explore associations between vitamin K intake (from dietary sources and supplements) and cardiovascular outcomes, including a potential inverse relationship with atherosclerotic cardiovascular disease, stroke, and peripheral artery disease in some cohorts.[3]

• General interest and educational coverage emphasize vitamin K’s role in blood coagulation, the differences between dietary vitamin K1 and K2 (and their sources), and possible interactions with other nutrients or medications.[6][7]

• For broader context, there’s ongoing media coverage tying vitamin K status to heart health and nutrition, with recommendations to include green leafy vegetables and certain fats in the diet to support absorption and function.[7][3]

If you’d like, I can narrow to a specific angle (e.g., newborn vitamin K policy, regulatory news, or dietary intake research) and pull more precise, up-to-date summaries with citations.